Thu, Oct 2, 2014, 1:06 PM EDT - U.S. Markets close in 2 hrs 54 mins

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • qdelfan qdelfan Aug 3, 2013 12:58 PM Flag

    Upcoming annual medical conferences where important clinical data realeases expected

    NACF (national Cf meeting) Oct. 19
    ACR (national rheumatology meeting) Oct 25
    AASLD (national hepatology meeting) Nov 1 through Nov 5

    Over the two weeks from Oct 19 through Nov 5 expect new data on the CF RA and hep C drugs in development from Vertex (if not released earlier), and well as announcements of partnership/licensing deals for ongoing development of VX 509 and VX 787. These represent a flurry of data that will likely enhance analyst valuation of VRTX projected growth over the next few years, and likely push the stock higher in price.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VRTX
104.70-2.55(-2.38%)1:05 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.